Shari Pilon‐Thomas
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cytokine Signaling Pathways and Interactions
Papers in
- Immunology 82
- Immunotherapy and Immune Responses 62
- Immune Cell Function and Interaction 19
- T-cell and B-cell Immunology 10
- Immune cells in cancer 10
- Oncology 76
- CAR-T cell therapy research 44
- Cancer Immunotherapy and Biomarkers 41
- Co-authors
- James J. Mulé (27 shared papers)Amod A. Sarnaik (35 shared papers)Krithika N. Kodumudi (22 shared papers)Amy Weber (14 shared papers)Arig Ibrahim‐Hashim (10 shared papers)Robert J. Gillies (10 shared papers)Guilian Niu (1 shared paper)H. David Kay (1 shared paper)
- Journals
- Cancer Research (11 papers)Journal of Clinical Oncology (8 papers)Journal for ImmunoTherapy of Cancer (8 papers)PLoS ONE (7 papers)Cancer Immunology Immunotherapy (6 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Shari Pilon‐Thomas
108 papers receiving 3.8k citations
Shari Pilon‐Thomas's Hit Papers
Peers
Comparison fields: 5 of 109
- Immunology 2.3k
- Oncology 2.2k
- Cancer Research 590
- Modeling and Simulation 85
- Molecular Biology 1.1k
Countries citing papers authored by Shari Pilon‐Thomas
This map shows the geographic impact of Shari Pilon‐Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shari Pilon‐Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shari Pilon‐Thomas more than expected).
Fields of papers citing papers by Shari Pilon‐Thomas
This network shows the impact of papers produced by Shari Pilon‐Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shari Pilon‐Thomas. The network helps show where Shari Pilon‐Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Shari Pilon‐Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity Hit paper breakdown → | 2005 | 813 |
| 2 | Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy Hit paper breakdown → | 2016 | 468 |
| 3 | 2018 | 168 | |
| 4 | 2012 | 143 | |
| 5 | 2020 | 119 | |
| 6 | 2010 | 117 | |
| 7 | 2021 | 117 | |
| 8 | 2016 | 116 | |
| 9 | 2019 | 109 | |
| 10 | 2013 | 104 | |
| 11 | 2012 | 100 | |
| 12 | 2008 | 76 | |
| 13 | 2018 | 75 | |
| 14 | 2019 | 67 | |
| 15 | 2016 | 57 | |
| 16 | 2023 | 56 | |
| 17 | 2013 | 54 | |
| 18 | 2013 | 54 | |
| 19 | 2014 | 48 | |
| 20 | 2018 | 46 |
About Shari Pilon‐Thomas
Shari Pilon‐Thomas is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, having authored 116 papers that have together received 3.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (62 papers), CAR-T cell therapy research (44 papers), Cancer Immunotherapy and Biomarkers (41 papers), Immune Cell Function and Interaction (19 papers), T-cell and B-cell Immunology (10 papers), Immune cells in cancer (10 papers), Cancer Research and Treatments (9 papers) and Cancer, Hypoxia, and Metabolism (9 papers). The work is most often cited by research in Immunology (2.3k citations), Oncology (2.2k citations), Cancer Research (590 citations), Modeling and Simulation (85 citations) and Molecular Biology (1.1k citations). Shari Pilon‐Thomas has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include James J. Mulé, Amod A. Sarnaik, Krithika N. Kodumudi, Amy Weber, Arig Ibrahim‐Hashim, Robert J. Gillies, Guilian Niu, H. David Kay, Maciej Kujawski and Marcin Kortylewski. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, PLoS ONE and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.